4.45EUR
927.75 MEUR
6.70 BEUR
204.81 M
About ZIMMER BIOMET HLDGS DL-01
Sector
Industry
CEO
Ivan Tornos
Website
Headquarters
Warsaw
Employees (FY)
18 K
Founded
1927
ISIN
US98956P1021
FIGI
BBG000CSMP13
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ZIMMER BIOMET HLDGS DL-01 stocks are traded under the ticker ZIM.
ZIMMER BIOMET HLDGS DL-01 is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ZIMMER BIOMET HLDGS DL-01 has a max estimate of 150.40 EUR and a min estimate of 102.45 EUR.
ZIM earnings for the last quarter are 1.56 EUR whereas the estimation was 1.51 EUR which accounts for 3.27% surprise. Estimated earnings for the next quarter are 1.95 EUR. See more details about ZIMMER BIOMET HLDGS DL-01 earnings.
ZIMMER BIOMET HLDGS DL-01 revenue for the last quarter amounts to 1.66 B EUR despite the estimated figure of 1.65 B EUR. In the next quarter revenue is expected to reach 1.75 B EUR.
Yes, you can track ZIMMER BIOMET HLDGS DL-01 financials in yearly and quarterly reports right on TradingView.
Like other stocks, ZIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZIMMER BIOMET HLDGS DL-01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 18.00 K employees. See our rating of the largest employees — is ZIMMER BIOMET HLDGS DL-01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZIMMER BIOMET HLDGS DL-01 EBITDA is 2.11 B EUR, and current EBITDA margin is 31.63%. See more stats in ZIMMER BIOMET HLDGS DL-01 financial statements.